Literature DB >> 9924440

Proposal for the assessment of quantitative dermal exposure limits in occupational environments: Part 1. Development of a concept to derive a quantitative dermal occupational exposure limit.

P M Bos1, D H Brouwer, H Stevenson, P J Boogaard, W L de Kort, J J van Hemmen.   

Abstract

Dermal uptake of chemicals at the workplace may contribute considerably to the total internal exposure and so needs to be regulated. At present only qualitative warning signs--the "skin notations"--are available as instruments. An attempt was made to develop a quantitative dermal occupational exposure limit (DOEL) complementary to respiratory occupational exposure limits (OELs). The DOEL refers to the total dose deposited on the skin during a working shift. Based on available data and experience a theoretical procedure for the assessment of a DOEL was developed. A DOEL was derived for cyclophosphamide and 4,4-methylene dianiline (MDA) according to this procedure. The DOEL for MDA was tested for applicability in an actual occupational exposure scenario. An integrated approach is recommended for situations in which both dermal and respiratory exposures contribute considerably to the internal exposure of the worker. The starting point should be an internal health based occupational exposure limit--that is, the maximum dose to be absorbed without leading to adverse systemic effects. The proposed assessment of an external DOEL is then either based on absorption rate or absorption percentage. The estimation of skin penetration seems to be of crucial importance in this concept. If for a specific substance a maximal absorption rate can be estimated a maximal skin surface area to be exposed can be assessed which may then serve the purpose of a DOEL. As long as the actual skin surface exposed is smaller than this maximal skin surface area the internal OEL will not be exceeded, and therefore, no systemic health problems would be expected, independent of the dermal dose/unit area. If not, the DOEL may be interpreted as the product of dermal dose/unit area (mg/cm2) and exposed skin surface area (cm2). The proposed concept for a DOEL is relevant and can be made applicable for health surveillance in the occupational situation where dermal exposure contributes notably to the systemic exposure. Further research should show whether this concept is more generally applicable.

Entities:  

Mesh:

Year:  1998        PMID: 9924440      PMCID: PMC1757540          DOI: 10.1136/oem.55.12.795

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  23 in total

Review 1.  Cutaneous metabolism of xenobiotics.

Authors:  J Kao; M P Carver
Journal:  Drug Metab Rev       Date:  1990       Impact factor: 4.518

2.  The metabolism of cyclophosphamide. Dose dependency and the effect of long-term treatment with cyclophosphamide.

Authors:  H T Mouridsen; O Faber; L Skovsted
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

Review 3.  Preventing percutaneous absorption of industrial chemicals: the "skin" denotation.

Authors:  P Grandjean; A Berlin; M Gilbert; W Penning
Journal:  Am J Ind Med       Date:  1988       Impact factor: 2.214

4.  Dermal absorption potential of industrial chemicals: criteria for skin notation.

Authors:  V Fiserova-Bergerova; J T Pierce; P O Droz
Journal:  Am J Ind Med       Date:  1990       Impact factor: 2.214

Review 5.  Sensory irritation by airborne chemicals.

Authors:  Y Alarie
Journal:  CRC Crit Rev Toxicol       Date:  1973-11

6.  The biotransformation of cyclophosphamide in man: analysis of the variation in normal subjects.

Authors:  H T Mouridsen; O Faber; L Skovsted
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1974-08

7.  Skin notation in the context of workplace exposure standards.

Authors:  G Scansetti; G Piolatto; G F Rubino
Journal:  Am J Ind Med       Date:  1988       Impact factor: 2.214

8.  Urinary cyclophosphamide excretion in rats after intratracheal, dermal, oral and intravenous administration of cyclophosphamide.

Authors:  P J Sessink; P H van den Broek; R P Bos
Journal:  J Appl Toxicol       Date:  1991-04       Impact factor: 3.446

9.  Percutaneous absorption of 2-butoxyethanol vapour in human subjects.

Authors:  G Johanson; A Boman
Journal:  Br J Ind Med       Date:  1991-11

Review 10.  Assessment of the developmental risks resulting from occupational exposure to select glycol ethers within the semiconductor industry.

Authors:  D J Paustenbach
Journal:  J Toxicol Environ Health       Date:  1988
View more
  4 in total

1.  Conceptual model for assessment of dermal exposure.

Authors:  T Schneider; R Vermeulen; D H Brouwer; J W Cherrie; H Kromhout; C L Fogh
Journal:  Occup Environ Med       Date:  1999-11       Impact factor: 4.402

Review 2.  Dermal exposure to chemicals in the workplace: just how important is skin absorption?

Authors:  S Semple
Journal:  Occup Environ Med       Date:  2004-04       Impact factor: 4.402

3.  Antineoplastic drug contamination in the urine of Canadian healthcare workers.

Authors:  Chun-Yip Hon; Kay Teschke; Hui Shen; Paul A Demers; Scott Venners
Journal:  Int Arch Occup Environ Health       Date:  2015-01-28       Impact factor: 3.015

4.  Environmental Contamination and Occupational Exposure of Algerian Hospital Workers.

Authors:  Eline Verscheure; Matteo Creta; Jeroen Vanoirbeek; Meziane Zakia; Taleb Abdesselam; Robin Lebegge; Katrien Poels; Radu-Corneliu Duca; Lode Godderis
Journal:  Front Public Health       Date:  2020-08-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.